Passage Bio Q1 EPS $(0.79) Beats $(0.89) Estimate

Passage Bio (NASDAQ:PASG) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.89) by 11.24 percent. This is a 3.95 percent decrease over losses of $(0.76) per share from the

Passage Bio (NASDAQ:PASG) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.89) by 11.24 percent. This is a 3.95 percent decrease over losses of $(0.76) per share from the same period last year.

Total
0
Shares
Related Posts
Read More

Macau Lockdown Slashes Targets For Las Vegas Sands, MGM, Wynn — Try These 3 US Casino Stocks Instead

Gambling stocks traded sharply lower on Monday morning as Macau casinos shut down for a week. In response, one Wall Street analyst cut his price targets for U.S.-listed casino stocks with exposure to Macau. The Analyst: Bank of America analyst Shaun Kelley issued the following price target cuts on Monday:

BYD